1. COVID-19 vaccine trials are underway in Dallas-Fort Worth  The Dallas Morning News
  2. 4 phases of COVID-19 vaccine clinical trials explained | USA TODAY  USA TODAY
  3. Dozens of COVID-19 vaccines are in development. Here are the ones to follow.  National Geographic
  4. How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill  The Hill
  5. Newsmakers: For Sarah Gilbert and Stephane Bancel, failure isn't an option in the search for COVID-19 vaccine  Gulf News
  6. View Full Coverage on Google News

Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.

Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.

A Covid-19 vaccine, amazingly, is close. Why am I so worried? - STAT

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.

Vaccine nationalism: Rich nations spend BILLIONS to grab first anti-coronavirus doses while poor countries are left behind (again) — RT Op-ed

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

COVID-19 vaccine cold war! - The Peninsula Qatar

Three vaccines are in final-stage trials and a fourth is nearly there.Three vaccines are in final-stage trials and a fourth is nearly there.

The Health 202: These are the top coronavirus vaccines to watch - The Washington Post

It's dog eat dog in the world of COVID-19 vaccines.It's dog eat dog in the world of COVID-19 vaccines.

'Vaccine nationalism': Is it every country for itself? - Reuters

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

Even if some Americans opt out, the country will still reach herd immunity against COVID-19.Even if some Americans opt out, the country will still reach herd immunity against COVID-19.

People Are Suffering Too Much to Refuse a Vaccine - The Atlantic

As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.

COVID-19 Prevention Network seeking volunteers for vaccine clinical trial | abc7.com

The coronavirus stories Medscape''s editors around the globe think you need to know about today.The coronavirus stories Medscape''s editors around the globe think you need to know about today.

COVID-19 Update: PPI Risk, Aerosol Transmission

India News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SIndia News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (S

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate | India News - Times of India

403 Forbidden

WHO urges countries to support 'COVAX' vaccine scheme - CGTN

The first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters. Moderna and Pfizer, which has partnered with Germany’s BioNTech, thisThe first two COVID-19 vaccines to enter large-scale U.S. trials will not be tested in pregnant women this year, raising questions about how this vulnerable population will be protected from the coronavirus, researchers told Reuters. Moderna and Pfizer, which has partnered with Germany’s BioNTech, this

Large U.S. COVID-19 vaccine trials will exclude pregnant women for now

The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...

Are Covid Vaccine Stocks Worth Investing In?

The official cautioned that there is still uncertainty around the timing of when a vaccine will actually be available.The official cautioned that there is still uncertainty around the timing of when a vaccine will actually be available.

US to launch 'overwhelming' COVID-19 vaccine campaign by November - The Jerusalem Post

KNOXVILLE, Tenn. (WATE) – A coronavirus vaccine trial is now underway in Knoxville and they’re looking for hundreds of volunteers.  Pfizer’s phase two and three study, part of the federal program Operation Warp Speed, aims to get a COVID-19 vaccine to the public as quickly as possible. Doctor William Smith, principal investigator of the study, […]KNOXVILLE, Tenn. (WATE) – A coronavirus vaccine trial is now underway in Knoxville and they’re looking for hundreds of volunteers.  Pfizer’s phase two and three study, part o…

Knoxville coronavirus vaccine trial underway, more volunteers sought | WATE 6 On Your Side

SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA | WOAI

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA

AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.

AstraZeneca reports good progress of Covid-19 vaccine in trials

Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem. Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem.

How Americans Became Hesitant About Covid-19 Vaccines: A Q&A With Walter Orenstein - Barron's

AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.

AstraZeneca: Won’t profit from COVID-19 vaccine in pandemic | coronavirus outbreak News,The Indian Express

On July 27, 2020, the Washington Post reported, Two coronavirus vaccines begin the last phase of testing: 30,000-person trials, wrapping it in historical terms: Getty Images At 6:45 a.m. Monday, a volunteer in Savannah, Ga., received a shot in the arm and became the first participant in a massive human experiment that will test the effectiveness of …

Things you should think about when you hear “vaccine by end of the year” |

Top expert at Northwestern says unprecedented speed of the process not worrisomeTop expert at Northwestern says unprecedented speed of the process not worrisome

COVID-19 vaccine could be ready for production in months if Phase 3 trial goes well | Northwest Herald

In a pandemic as serious and widespread as the COVID-19 crisis, hope lies in a vaccine.

What it’s like to be a participant in a COVID-19 vaccine trial | Decaturish - Locally sourced news

Clinical trials in Canada of an early Chinese front runner in the race for a coronavirus vaccine are in limbo, with Chinese customs authorities holding up shipment of the injections for weeks.Health Canada gave approval for clinical trials for Ad5-nCoV, a potential vaccine developed jointly by Tianjin-basedClinical trials in Canada of an early Chinese front runner in the race for a coronavirus vaccine are in limbo, with Chinese customs authorities holding up shipment of the injections for weeks.Health Canada gave approval for clinical trials for Ad5-nCoV, a potential vaccine developed jointly by Tianjin-based

Coronavirus: Chinese customs stalls vaccine shipment for trials in Canada

Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.

Commentary: Booster shots will likely be needed even if a COVID-19 vaccine is ready - CNA

Coronavirus vaccine prices have been revealed or leaked for some of the companies at the forefront of COVID-19 vaccine research. Some pharmaceutical firms are looking to make a profit off of COVID-19 vaccines in the coming years.Coronavirus vaccine prices have been revealed or leaked for some of the companies at the forefront of COVID-19 vaccine research. Some pharmaceutical firms are looking to make a profit off of COVID-…

Here’s how much coronavirus vaccines might cost – BGR

The Phase 3 trial is expected to recruit 30,000 volunteers who will receive two injections of either the vaccine or a placebo

Georgia News Anchor Becomes First Person to Receive COVID-19 Vaccine Shot in Phase 3 Trial

Even if a fully effective vaccine can be developed and deployed quickly, it won’t mean an immediate return to normal life or business.And it won’t mean an immediate return to normal life.

A vaccine isn’t going to be a magic cure for the COVID-19 pandemic - Marketplace

The first round of people participating in a COVID-19 vaccine trial in South Texas were given a dose Thursday.The first round of people participating in a COVID-19 vaccine trial in South Texas were given a dose Thursday.

COVID-19 vaccine trial underway in South Texas

Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, according to Dr. Anthony Fauci, which is the standard for vaccines.Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, ac…

This might be the best coronavirus vaccine news you’ve ever heard – BGR

Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment.

AstraZeneca: won't profit from COVID-19 vaccine in pandemic

Dawn Baker, an anchor at CNN affiliate WTOC in Savannah, made history on Monday as the first volunteer to take the injection in the United States.Dawn Baker, an anchor at CNN affiliate WTOC in Savannah, made history on Monday as the first volunteer out of 30,000, to take the injection in the United States.

Georgia News Anchor First Participant In COVID-19 Vaccine Trial | MadameNoire

Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work. Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.

China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes

Human challenge trials and equitable distribution of vaccines were extensively discussed in this symposiumHuman challenge trials and equitable distribution of vaccines were extensively discussed in this symposium

Human Challenge Trial For COVID-19 Unnecessary: Anthony Fauci At ICMR Event